Loading…

Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy

Background This study was carried out to determine if markers of nutritional status predict for locoregional failure following intensity‐modulated radiation therapy (IMRT) with concurrent chemoradiotherapy (CCRT) for squamous cell carcinoma of the head and neck (SCCHN). Methods We performed a retros...

Full description

Saved in:
Bibliographic Details
Published in:Head & neck 2011-11, Vol.33 (11), p.1561-1568
Main Authors: Platek, Mary E., Reid, Mary E., Wilding, Gregory E., Jaggernauth, Wainwright, Rigual, Nestor R., Hicks Jr, Wesley L., Popat, Saurin R., Warren, Graham W., Sullivan, Maureen, Thorstad, Wade L., Khan, Mohamed K., Loree, Thom R., Singh, Anurag K.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background This study was carried out to determine if markers of nutritional status predict for locoregional failure following intensity‐modulated radiation therapy (IMRT) with concurrent chemoradiotherapy (CCRT) for squamous cell carcinoma of the head and neck (SCCHN). Methods We performed a retrospective chart review of 78 patients with SCCHN who received definitive CCRT. We compared patient factors, tumor characteristics, and nutritional status indicators between patients with and without locoregional failure. Results Fifteen of 78 patients (19%) experienced locoregional failure. Median follow‐up for live patients was 38 months. On univariate analysis, pretreatment percentage of ideal body weight (%IBW) (p < .01), pretreatment hemoglobin (p = .04), and treatment duration (p < .01) were significant predictors of failure. On multivariate analysis, pretreatment %IBW (p = .04) and treatment time (p < .01) remained statistically significant. Conclusions Although treatment time is an accepted risk factor for failure, differences in outcome for patients with head and neck cancer undergoing definitive CCRT based on pretreatment %IBW should be examined further. © 2010 Wiley Periodicals, Inc. Head Neck, 2011
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.21640